Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT02772081 Terminated - Clinical trials for Respiratory Distress Syndrome (RDS)

A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional Administration

LISPAP
Start date: May 18, 2021
Phase: Phase 3
Study type: Interventional

This study compared the administration of porcine surfactant (poractant alfa, Curosurf®) through a less invasive method (LISA), using a thin catheter, CHF 6440 (LISACATH®), during non-invasive ventilation (CPAP, NIPPV, BiPAP) with an approved conventional surfactant administration during invasive ventilation followed by rapid extubation in terms of short term and mid-term safety and efficacy in spontaneously breathing preterm neonates who have clinical signs of respiratory distress syndrome (RDS).

NCT ID: NCT02771080 Completed - Clinical trials for Low Cardiac Output Syndrome After Adult Cardiac Surgery

Peak Systolic Global Longitudinal Strain and Low Cardiac Output Syndrome After Cardiac Surgery

Start date: June 2016
Phase: N/A
Study type: Observational

This is a retrospective observational study to assess the relationship between peak systolic global longitudinal strain measured on pre-cardiopulmonary bypass trans-esophageal echo images predicts post-operative low cardiac output syndrome defined as the need for an inotropic support during 24 hours or longer.

NCT ID: NCT02770716 Completed - Clinical trials for Hepatorenal Syndrome

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

Start date: July 13, 2016
Phase: Phase 3
Study type: Interventional

This study is to treat adult patients with hepatorenal syndrome (HRS) Type 1. Out of every three participants, two will receive terlipressin and one will receive placebo. Assignments will be made randomly.

NCT ID: NCT02768844 Completed - Clinical trials for Neonatal Abstinence Syndrome

Physiology and Therapeutic Management of Neonatal Abstinence Syndrome

Start date: April 2011
Phase: N/A
Study type: Interventional

The overall purpose of this project is to to quantify the physiology of neonatal drug withdrawal and develop non-pharmacological techniques to help improve the therapeutic management of Neonatal Abstinence Syndrome (NAS).

NCT ID: NCT02767960 Completed - Clinical trials for Acute Coronary Syndrome

Serum Tenascin-C Concentration in Patients With Acute Coronary Syndrome

Start date: May 2016
Phase: N/A
Study type: Observational [Patient Registry]

This study valuates the serum Tenascin-C concentration in patients with acute coronary syndrome.

NCT ID: NCT02767869 Completed - Clinical trials for Metabolic Syndrome X

Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity

Start date: January 2015
Phase: Phase 2
Study type: Interventional

The Metabolic Syndrome is a high prevalence disease worldwide. About a quarter of the adult population suffers the disease. Banaba has shown evidence that has on metabolic syndrome, insulin sensitivity and insulin secretion. The investigators hypothesis was that the the administration of resveratrol modifies the metabolic syndrome, insulin sensitivity and insulin secretion.

NCT ID: NCT02766413 Completed - Clinical trials for Carpal Tunnel Syndrome

Carpal Tunnel Release Through Mini Transverse Approach

CTRMTA
Start date: February 2013
Phase: N/A
Study type: Interventional

Carpal tunnel release through dorsal wrist crease Mini Transverse incision, about 1.5 cm length.

NCT ID: NCT02765711 Recruiting - Clinical trials for Acute Coronary Syndrome

Ticagrelor in Fuwai Hospital

TIFU
Start date: May 2016
Phase: N/A
Study type: Observational

This is a single-arm non-interventional cohort study. This study is to describe the contemporary use of ticagrelor in a "real-world" setting, to reflect its acceptance and patients' compliance, and to observe its one-year safety in patients with acute coronary syndrome in Fuwai Hospital.

NCT ID: NCT02765178 Completed - Tourette Syndrome Clinical Trials

Apathy in Tourette Syndrome and Changes in Quality of Life

Start date: April 2016
Phase: N/A
Study type: Observational

Tourette syndrome is a complex neuropsychological disorder with both motor and vocal tics associated with multiple psychological co-morbidities. Apathy has not been widely studied in patients with Tourette syndrome. Apathy can result in decrease in self-care and disease control. In this study investigators will compare the occurrence of apathy in the adolescent Tourette syndrome population (at the UF center for movement disorders and Neurorestoration) to an age and gender matched control population. Investigators will also assess the role of commonly used medications in the Tourette population (neuroleptics and selective serotonin receptor inhibitors) in the occurrence of apathy.

NCT ID: NCT02764957 Completed - Metabolic Syndrome Clinical Trials

Green Coffee Extract and Metabolic Syndrome

Start date: December 1, 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Metabolic syndrome (Mets) is an assemblage of risk factors which can increase the risk of developing type 2 diabetes mellitus and cardiovascular disease. Green coffee extract (GCE) is derived from unroasted coffee beans and has substantial amounts of polyphenols primarily chlorogenic acids (CGA). It has been shown that GCE and CGA can exert a positive influence over Mets components including blood pressure, blood glucose, inflammation, oxidative stress, insulin resistance and blood lipids. Up to our knowledge no study has been conducted on humans in the field of GCA influences on Mets patients. Therefore, this study is planned to evaluate GCA supplementation effects on anthropometric measurements, glycemic control, blood pressure, lipid profile in patients with metabolic syndrome.